For the month of March 2019, Cadence Capital Limited returned a negative gross performance of 1.9% compared to an increase in the All Ordinaries Accumulation Index of 0.7%. For the month, the largest contributor to the Company’s performance was Shine Corporate and the largest detractors from performance were Emeco Holdings, Money3 Corporation and Seven Group. Over the coming week the company will be releasing its March 2019 Quarterly webcast where it will be giving a detailed update on both the company’s performance over the past quarter and its current holdings.
At 31st March 2019, the Company was 80.4% invested (19.6% cash).
In February the Company announced a 3.0 cent fully franked interim dividend. This equated to a 6.8% annual fully franked yield (9.7% gross yield) based on the CDM share price at the time of the announcement. The Ex-Date for the dividend is the 29th April 2019 and the payment date is the 13th May 2019. The DRP is not operational for the Interim Dividend.
* Gross Performance: before Management and Performance Fees
CDM Share Price and Option Returns plus Dividends & Franking
Fully Franked Dividends Declared Since Listing
Historic Portfolio Exposure
Portfolio Sector Analysis
Top Portfolio Position
Cadence Capital Limited (CDM) was recently highlighted as a Listed Investment Company (LIC) to watch in the Bell Potter Research article on Livewire Markets titled Looking for opportunity in LIC land. This article discusses the potential investment opportunities presented where a LIC’s share price is trading at a discount to its NTA.
We encourage you to visit our 52 books you should read before buying your next stock page on our website. We have compiled a list of books/ documentaries that have influenced our investment style or helped provide insight into the investment process. To view all previous Cadence webcasts and press articles, please visit the Media Section of the website.
We welcome any of your friends or colleagues that you feel may benefit from our monthly Cadence Capital Limited Newsletter. Please click here to refer a friend by supplying their name and email address.